2 Minute Medicine Rewind February 15, 2016
Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a contemporary chemotherapy protocol Acute lymphoblastic ...
Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a contemporary chemotherapy protocol Acute lymphoblastic ...
Originally published by Harvard Health. What Is It? Acute lymphocytic leukemia (ALL) is a type of leukemia. Leukemia is a ...
1. 90% of relapsed B-cell acute lymphoblastic leukemia (ALL) patients achieved complete remission 1 month after an infusion of engineered ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Angiotensin–Neprilysin ...
1. The prevalence of Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) increased with age and was associated with worse overall ...
Image: PD 1. Delaying the first round of triple intrathecal therapy (TIT) until peripheral blasts were cleared improved CNS ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.